Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection-Reference-Cited by-同舟云学术

Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection

Published:2005-02-08 Issue:1 Volume:8 Page:66-68
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Montgomery B S I,Borwell J P,Higgins D M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500778.pdf

Reference17 articles.

1. Parkin DM, Bray FI, Devesa SS . Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8): S4–S66.

2. Kaisary AV et al. Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma. Br J Urol 1991; 67: 502–508.

3. Vogelzang NJ et al. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Urology 1995; 46: 220–226.

4. The Leuprolide Study Group. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 1984; 311: 1281–1286.

5. Prayer-Galetti T et al. Disease free survival in patients with pathological ‘C STAGE’ prostate cancer at radical retropubic prostatectomy submitted to adjuvant hormonal treatment. Eur Urol 2000; 38: 504 (abstract 48).

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From in vitro to in vivo: A comprehensive guide to IVIVC development for long-acting therapeutics;Advanced Drug Delivery Reviews;2023-08

2. Changing the daily injection of glatiramer acetate to a monthly long acting product through designing polyester-based polymeric microspheres;BioImpacts;2022-08-13

3. Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules;Expert Opinion on Drug Delivery;2022-07-28

4. Preparation of Long-Acting Somatostatin and GnRH Analogues and Their Applications in Tumor Therapy;Current Drug Delivery;2022-01

5. Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety;Indian Journal of Cancer;2022